If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.
Toplexil Side Effects Reported to FDA
Toplexil Side Effect Report#8446028-6 Pancreatitis Acute
This is a report of a 65-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: cough,metastatic malignant melanoma, who was treated with Toplexil (france) (dosage: Dose: 3 Or 4 Doseform, start time:
Jan 02, 2012), combined with:
and developed a serious reaction and side effect(s): Pancreatitis Acute after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Toplexil (france) treatment in male patients, resulting in Pancreatitis Acute side effect.
Toplexil Side Effect Report#6202319-0 Leukopenia, Neutropenia
This report suggests a potential Toplexil /01513001/Leukopenia side effect(s) that can have serious consequences. A 23-year-old female patient (weight: NA) from was diagnosed with the following symptoms/conditions: bronchitis and used Toplexil /01513001/ (dosage: NA) starting
Mar 31, 2009. After starting Toplexil /01513001/ the patient began experiencing various side effects, including: Leukopenia, NeutropeniaAdditional drugs used concurrently:
The patient was hospitalized. Although Toplexil /01513001/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Leukopenia, may still occur.
This Diarrhoea problem was reported by a consumer or non-health professional from . A 34-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: cough,bronchitis acute. On
Nov 28, 2005 this consumer started treatment with Toplexil ^theraplix^ (dosage: NA). The following drugs were being taken at the same time:
When using Toplexil ^theraplix^, the patient experienced the following unwanted symptoms/side effects: Diarrhoea, Gastrointestinal Disorder, Hepatitis Cholestatic, Hypergammaglobulinaemia Benign MonoclonalThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Diarrhoea, may become evident only after a product is in use by the general population.
This Abdominal Pain side effect was reported by a consumer or non-health professional from . A 34-year-old male patient (weight:NA) experienced the following symptoms/conditions: cough,bronchitis acute.The patient was prescribed Toplexil ^theraplix^ (drug dosage: NA), which was initiated on
Nov 28, 2005. Concurrently used drugs:
.After starting to take Toplexil ^theraplix^ the consumer reported adverse symptoms, such as: Abdominal Pain, Abdominal Pain Lower, Ascites, Diarrhoea, Gastrointestinal Disorder, Hepatitis Cholestatic, Hypergammaglobulinaemia Benign Monoclonal, Intestinal Villi AtrophyThese side effects may potentially be related to Toplexil ^theraplix^. The patient was hospitalized.
This is a report of a 34-year-old male patient (weight: NA) from , suffering from the following health symptoms/conditions: cough,bronchitis acute, who was treated with Toplexil ^theraplix^ (dosage: NA, start time:
Nov 28, 2005), combined with:
and developed a serious reaction and side effect(s): Diarrhoea, Gastrointestinal Disorder, Hepatitis Cholestatic, Hypergammaglobulinaemia Benign Monoclonal after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Toplexil ^theraplix^ treatment in male patients, resulting in Diarrhoea side effect. The patient was hospitalized.
The appearance of Toplexil on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.
Why Your Notes are Important
Your notes could be helpful in several ways:
You can use them to remind you of details that may alert your health care professional(s) to a problem
You will have a record to refer to in the future, in case you are ever prescribed the same medicine again
You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.
Medicine Name and Dosage:
Date & Time
Other Medicine(s) or Treatment(s)
Scale: 1 = very mild to 10 = very bad
Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Toplexil reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.